Clinical trial
A 6-week Randomised, Open Comparative, Multi-centre Study of Intravenous Ferric Carboxymaltose (Ferinject) and Oral Iron (Duroferon) for Treatment of Post Partum Anemia
NCT00929409 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 6-week Randomised, Open Comparative, Multi-centre Study of Intravenous Ferric Carboxymaltose (Ferinject) and Oral Iron (Duroferon) for Treatment of Post Partum Anemia
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- June 30, 2009
- Completion date
- July 31, 2010
- Enrollment
- 30 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.